Industry Experts Award Cutting-Edge Technology Exhibited at INTERPHEX
Bio-Rad's ZE5 Cell Analyzer
HERCULES, Calif. — April 5, 2017 — Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO.B), a global provider of life science research and clinical diagnostic products, today announced that its ZE5 Cell Analyzer was named the “Best New Product/Service” during International Pharmaceutical Expo (INTERPHEX) held in New York last month, an event dedicated to pharmaceutical and biotechnology innovation, technology, and knowledge from development through commercialization.
The Best New Product/Service Award is given to the event exhibitor that encourages, develops, and features the very best in new products or services showcasing knowledge, innovation, and state-of-the-art technologies leading to significant business, economic, or manufacturing benefits for the pharma and bio industries.
“We are honored to get this award and even more excited to introduce the industry to our ZE5 Cell Analyzer,” said Shannon Hall, Bio-Rad Executive Vice President, President, Life Science Group. “The ZE5 is just one product in a portfolio that Bio-Rad offers to address the growing area of cellular analysis, which enables a deep view into the genomics, proteomics, and morphology of individual cells to help better understand their functions in complex tissues and human disease.”
The ZE5 Cell Analyzer is an innovative flow cytometer with flexible configurations to meet a broad range of experimental complexities and throughput needs, providing the industry with its first expandable flow cytometer. This flexibility makes the ZE5 Analyzer accessible for novice users yet powerful enough for the most experienced professionals. A fully integrated sample loader with the ability to handle tubes or plates without an instrument hardware change enables true walk-away functionality.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) develops, manufactures, and markets a broad range of innovative products and solutions for the life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and healthcare industry customers through its global network of operations. The Company employs more than 8,250 people worldwide and had revenues exceeding $2 billion in 2016. For more information, please visit www.bio-rad.com.
Press Contact:
Bio-Rad Laboratories, Inc.
Tina Cuccia, Corporate Communications
510-741-6063
tina_cuccia@bio-rad.com